These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6128357

  • 1. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness.
    Grewe SR, Chan SC, Hanifin JM.
    J Allergy Clin Immunol; 1982 Dec; 70(6):452-7. PubMed ID: 6128357
    [Abstract] [Full Text] [Related]

  • 2. Heterologous desensitization of leukocytes: a possible mechanism of beta adrenergic blockade in atopic dermatitis.
    Safko MJ, Chan SC, Cooper KD, Hanifin JM.
    J Allergy Clin Immunol; 1981 Sep; 68(3):218-25. PubMed ID: 6114971
    [Abstract] [Full Text] [Related]

  • 3. Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis.
    Butler JM, Chan SC, Stevens S, Hanifin JM.
    J Allergy Clin Immunol; 1983 May; 71(5):490-7. PubMed ID: 6188771
    [Abstract] [Full Text] [Related]

  • 4. Lymphocyte and monocyte localization of altered adrenergic receptors, cAMP responses, and cAMP phosphodiesterase in atopic dermatitis. A possible mechanism for abnormal radiosensitive helper T cells in atopic dermatitis.
    Cooper KD, Chan SC, Hanifin JM.
    Acta Derm Venereol Suppl (Stockh); 1985 May; 114():41-7. PubMed ID: 2988252
    [No Abstract] [Full Text] [Related]

  • 5. Peripheral blood mononuclear leukocyte cyclic adenosine monophosphate specific phosphodiesterase activity in childhood atopic dermatitis.
    Coulson IH, Duncan SN, Holden CA.
    Br J Dermatol; 1989 May; 120(5):607-12. PubMed ID: 2547417
    [Abstract] [Full Text] [Related]

  • 6. [Changed phosphodiesterase activity of leukocytes in atopic eczema].
    Hanifin JM.
    Hautarzt; 1987 May; 38(5):258-61. PubMed ID: 3038785
    [Abstract] [Full Text] [Related]

  • 7. Functional desensitization due to stimulation of cyclic AMP-phosphodiesterase in human mononuclear leukocytes.
    Chan SC, Grewe SR, Stevens SR, Hanifin JM.
    J Cyclic Nucleotide Res; 1982 May; 8(4):211-24. PubMed ID: 6300207
    [Abstract] [Full Text] [Related]

  • 8. Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis.
    Holden CA, Chan SC, Hanifin JM.
    J Invest Dermatol; 1986 Sep; 87(3):372-6. PubMed ID: 3016107
    [Abstract] [Full Text] [Related]

  • 9. Leukocyte adherence in atopic dermatitis: diminished responses to histamine and isoproterenol.
    Thulin H, Hanifin JM, Bryant R.
    Acta Derm Venereol; 1980 Sep; 60(3):235-8. PubMed ID: 6158226
    [Abstract] [Full Text] [Related]

  • 10. Cyclic AMP-phosphodiesterase activity and histamine release in cord blood leukocyte preparations.
    McMillan JC, Heskel NS, Hanifin JM.
    Acta Derm Venereol Suppl (Stockh); 1985 Sep; 114():24-32. PubMed ID: 2408431
    [Abstract] [Full Text] [Related]

  • 11. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
    Lad PM, Goldberg BJ, Smiley PA, Olson CV.
    Biochim Biophys Acta; 1985 Aug 30; 846(2):286-95. PubMed ID: 2411298
    [Abstract] [Full Text] [Related]

  • 12. Immunochemical characterization of the distinct monocyte cyclic AMP-phosphodiesterase from patients with atopic dermatitis.
    Chan SC, Reifsnyder D, Beavo JA, Hanifin JM.
    J Allergy Clin Immunol; 1993 Jun 30; 91(6):1179-88. PubMed ID: 8389777
    [Abstract] [Full Text] [Related]

  • 13. Relationship between increased cyclic AMP-phosphodiesterase activity and abnormal adenylyl cyclase regulation in leukocytes from patients with atopic dermatitis.
    Hanifin JM, Lloyd R, Okubo K, Guerin LL, Fancher L, Chan SC.
    J Invest Dermatol; 1992 Jun 30; 98(6 Suppl):100S-105S. PubMed ID: 1316924
    [Abstract] [Full Text] [Related]

  • 14. Modulation of leukocyte cyclic AMP phosphodiesterase activity by recombinant interferon-gamma: evidence for a differential effect on atopic monocytes.
    Li SH, Chan SC, Kramer SM, Hanifin JM.
    J Interferon Res; 1993 Jun 30; 13(3):197-202. PubMed ID: 8396165
    [Abstract] [Full Text] [Related]

  • 15. Impaired lymphocyte cyclic adenosine monophosphate responses in atopic eczema.
    Archer CB, Morley J, MacDonald DM.
    Br J Dermatol; 1983 Nov 30; 109(5):559-64. PubMed ID: 6315045
    [Abstract] [Full Text] [Related]

  • 16. Elevated umbilical cord blood leukocyte cyclic adenosine monophosphate-phosphodiesterase activity in children with atopic parents.
    Heskel NS, Chan SC, Thiel ML, Stevens SR, Casperson LS, Hanifin JM.
    J Am Acad Dermatol; 1984 Sep 30; 11(3):422-6. PubMed ID: 6090514
    [Abstract] [Full Text] [Related]

  • 17. Immunopharmacology of the atopic diseases.
    Hanifin JM, Butler JM, Chan SC.
    J Invest Dermatol; 1985 Jul 30; 85(1 Suppl):161s-164s. PubMed ID: 2409183
    [Abstract] [Full Text] [Related]

  • 18. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
    Chan SC, Hanifin JM.
    J Lab Clin Med; 1993 Jan 30; 121(1):44-51. PubMed ID: 8381148
    [Abstract] [Full Text] [Related]

  • 19. Impaired monocyte cyclic AMP responses and monocyte cytotoxicity in atopic dermatitis.
    Herlin T, Kragballe K.
    Allergy; 1980 Dec 30; 35(8):647-55. PubMed ID: 6261605
    [Abstract] [Full Text] [Related]

  • 20. Cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from patients with atopic dermatitis: correlation with respiratory atopy.
    Sawai T, Ikai K, Uehara M.
    Br J Dermatol; 1998 May 30; 138(5):846-8. PubMed ID: 9666832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.